US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veradermics, Inc.

102.82

-2.5000-2.37%

Post-market: 102.820.00000.00%19:30 EDT

Volume:393.62K

Turnover:41.10M

Market Cap:4.30B

PE:-15.96

High:108.87

Open:105.18

Low:102.52

Close:105.32

52wk High:131.24

52wk Low:32.00

Shares:41.78M

Float Shares:26.54M

Volume Ratio:0.64

T/O Rate:1.48%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-6.4439

EPS(LYR):-111.9114

ROE:-72.06%

ROA:-43.45%

PB:5.28

PE(LYR):-0.92

Loading ...

Overview Company News Filings

Veradermics Inc : Citigroup Raises Target Price to $160 from $135

THOMSON REUTERS

Sector Update: Healthcare

MT Newswires Live

B. Riley Analyst Initiates Coverage of Veradermics Stock (MANE) With a Buy Rating

Veradermics Shares Gain Nearly 14% After Oral Hair Loss Drug Shows Positive Mid-stage Data in Women

THOMSON REUTERS

Veradermics rises 13.9%

Veradermics Shares Rise After Positive Midstage Hair-loss Trial Results

Positive Phase II Trial Results Announced for Veradermics' Female Hair Loss Treatment

B. Riley Initiates Veradermics at Buy With $170 Price Target

MT Newswires Live

U.S. Stocks on the Move-johnson & Johnson, Blackrock, Veradermics

Veradermics' Potential Female Hair Loss Treatment Restores Hair in Phase 2 Trial

MT Newswires Live

Veradermics Rises as Oral Hair Loss Drug Shows Positive Mid-stage Data in Women

Veradermics announces results from Phase 2 trial of VDPHL01

Veradermics’ Oral Vdphl01 Delivers Positive Study ‘207’ Phase 2 Clinical Trial Results in Female Pattern Hair Loss Ahead of Upcoming Phase 2/3 Study ‘306’ Readout

THOMSON REUTERS

Veradermics - Vdphl01 Shows Favorable Safety with no Treatment-related Serious Adverse Events or Cardiac Aesis

THOMSON REUTERS

Veradermics - Vdphl01 Shows 88.9%-90% Improvement in Hair Coverage at Month 6 in Phase 2 Study

THOMSON REUTERS

Veradermics Initiated at Buy by B. Riley Securities

Veradermics initiated with a Buy at B. Riley

Veradermics Inc : B. Riley Initiates Coverage with Buy Rating; Target Price $170

THOMSON REUTERS

Veradermics to Discuss Phase 2 Results for Oral Minoxidil Hair-loss Drug Vdphl01 on July 15 Webcast

Veradermics is Maintained at Buy by Jefferies

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/MANE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MANE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","market":"US","secType":"STK","nameCN":"Veradermics, Inc.","latestPrice":102.82,"timestamp":1787342400000,"preClose":105.32,"halted":0,"volume":393617,"hourTrading":{"tag":"盘后","latestPrice":102.82,"preClose":102.82,"latestTime":"19:30 EDT","volume":10632,"amount":1093288.29,"timestamp":1787355006654,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02373718192176225,"floatShares":26539200,"shares":41778687,"eps":-6.443948,"marketStatus":"Market Closed","change":-2.5,"latestTime":"08-21 16:00:00 EDT","open":105.18,"high":108.87,"low":102.52,"amount":41101845.331470005,"amplitude":0.060292,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.443948,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1770181200000,"exchange":"NYSE","adjPreClose":105.32,"preHourTrading":{"tag":"盘前","latestPrice":104,"preClose":105.32,"latestTime":"09:10 EDT","volume":179,"amount":18787.939524,"timestamp":1787317853011,"change":-1.32,"changeRate":-0.012533,"amplitude":0.040733},"postHourTrading":{"tag":"盘后","latestPrice":102.82,"preClose":102.82,"latestTime":"19:30 EDT","volume":10632,"amount":1093288.29,"timestamp":1787355006654,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6367700717110018,"impliedVol":0.9649,"impliedVolPercentile":0.3929},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","floatShares":26539200,"roa":"-43.45%","roe":"-72.06%","lyrEps":-111.911419,"volumeRatio":0.6367700717110018,"shares":41778687,"dividePrice":0,"high":108.87,"amplitude":0.060292,"preClose":105.32,"low":102.52,"week52Low":32,"pbRate":"5.28","week52High":131.2399,"institutionHeld":0,"latestPrice":102.82,"eps":-6.443948,"divideRate":0,"volume":393617,"delay":0,"ttmEps":-6.443948,"open":105.18,"prevYearClose":17,"prevWeekClose":112.71,"prevMonthClose":105,"prevQuarterClose":122.94,"fiveDayClose":112.71,"twentyDayClose":109.51,"sixtyDayClose":100.13},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MANE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"MANE","fiscalQuarterEnding":"2026/06","expectedEps":-0.58,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.58}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MANE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MANE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1784174400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MANE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MANE","date":"2026-08-21","current":-15.956057,"percent":0.50365,"low":-67.545361,"twenty":-54.602336,"median":-47.561116,"eighty":-33.713665,"high":-9.296992,"avg":-45.298569,"sd":11.240682,"marketCap":4400283923},"quantilePoints":[{"date":"2026-02-06","current":-25.786263,"twenty":-25.079893,"median":-17.8457,"eighty":-10.368249,"marketCap":1387507243},{"date":"2026-02-13","current":-30.838039,"twenty":-29.065754,"median":-25.786263,"eighty":-19.198356,"marketCap":1659333205},{"date":"2026-02-20","current":-33.530469,"twenty":-32.062123,"median":-28.069277,"eighty":-25.043809,"marketCap":1804207481},{"date":"2026-02-27","current":-29.776333,"twenty":-31.085076,"median":-29.967163,"eighty":-25.732137,"marketCap":1602204947},{"date":"2026-03-06","current":-33.738647,"twenty":-32.654736,"median":-30.560469,"eighty":-26.152655,"marketCap":1815409101},{"date":"2026-03-13","current":-35.785726,"twenty":-33.721993,"median":-31.049686,"eighty":-27.249057,"marketCap":1925558357},{"date":"2026-03-20","current":-39.491287,"twenty":-35.53175,"median":-31.816474,"eighty":-28.546698,"marketCap":2124947181},{"date":"2026-03-27","current":-46.874652,"twenty":-39.507941,"median":-32.867771,"eighty":-29.468231,"marketCap":2522231279},{"date":"2026-04-02","current":-31.356106,"twenty":-39.513493,"median":-32.867771,"eighty":-29.852665,"marketCap":2194770608},{"date":"2026-04-10","current":-31.99758,"twenty":-38.92088,"median":-32.857362,"eighty":-30.17702,"marketCap":2239670594},{"date":"2026-04-17","current":-39.540857,"twenty":-39.536494,"median":-33.608872,"eighty":-30.279902,"marketCap":2767662294},{"date":"2026-04-24","current":-36.942854,"twenty":-39.536494,"median":-33.738647,"eighty":-30.421684,"marketCap":2585815082},{"date":"2026-05-01","current":-52.813611,"twenty":-40.831905,"median":-34.49692,"eighty":-30.615983,"marketCap":3696688710},{"date":"2026-05-08","current":-63.45616,"twenty":-42.963163,"median":-35.411007,"eighty":-30.844978,"marketCap":4441613943},{"date":"2026-05-15","current":-51.496667,"twenty":-46.59847,"median":-35.988193,"eighty":-30.890717,"marketCap":4368307751},{"date":"2026-05-22","current":-50.831536,"twenty":-50.412067,"median":-36.702792,"eighty":-31.015444,"marketCap":4311886693},{"date":"2026-05-29","current":-50.670085,"twenty":-50.670085,"median":-37.508333,"eighty":-31.226637,"marketCap":4298191318},{"date":"2026-06-05","current":-49.857433,"twenty":-50.482929,"median":-39.295461,"eighty":-31.282151,"marketCap":4229256485},{"date":"2026-06-12","current":-46.493546,"twenty":-50.049515,"median":-39.519044,"eighty":-31.356106,"marketCap":3943908052},{"date":"2026-06-18","current":-45.24748,"twenty":-50.006173,"median":-40.004977,"eighty":-31.7244,"marketCap":3838207974},{"date":"2026-06-26","current":-58.79168,"twenty":-50.634624,"median":-40.906894,"eighty":-31.961359,"marketCap":4987121867},{"date":"2026-07-02","current":-63.278505,"twenty":-51.067836,"median":-42.661209,"eighty":-32.20951,"marketCap":5367725705},{"date":"2026-07-10","current":-61.520221,"twenty":-53.048338,"median":-44.057315,"eighty":-32.416525,"marketCap":5218575793},{"date":"2026-07-17","current":-52.123009,"twenty":-54.2625,"median":-44.976596,"eighty":-32.698555,"marketCap":4421438445},{"date":"2026-07-24","current":-57.062948,"twenty":-54.490042,"median":-45.472923,"eighty":-32.869852,"marketCap":4840478675},{"date":"2026-07-31","current":-51.531989,"twenty":-54.856474,"median":-45.794173,"eighty":-33.139095,"marketCap":4371304020},{"date":"2026-08-07","current":-53.511905,"twenty":-54.832834,"median":-46.684099,"eighty":-33.593192,"marketCap":4539254342},{"date":"2026-08-14","current":-50.036631,"twenty":-54.832834,"median":-47.316049,"eighty":-33.69117,"marketCap":4637595096},{"date":"2026-08-21","current":-47.476198,"twenty":-54.602336,"median":-47.561116,"eighty":-33.713665,"marketCap":4400283923}],"updateTime":1787457859833},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MANE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651445539","title":"Veradermics Inc : Citigroup Raises Target Price to $160 from $135","url":"https://stock-news.laohu8.com/highlight/detail?id=2651445539","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651445539?lang=en_us&edition=fundamental","pubTime":"2026-07-16 18:32","pubTimestamp":1784197943,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nFWN43I0YH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651849319","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2651849319","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651849319?lang=en_us&edition=fundamental","pubTime":"2026-07-16 03:28","pubTimestamp":1784143704,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose late Wednesday afternoon, with the NYSE Healthcare Index adding 0.3% and the State Street Health Care Select Sector SPDR ETF  increasing 0.1%.The iShares Biotechnology ETF  added 0.5%.In corporate news, Veradermics  shares jumped 13% after the company said its VDPHL01 achieved rapid onset of hair growth with the majority of participants in a phase 2 clinical trial of females with mild-to-moderate pattern hair loss.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","MANE","IBB","LU0128526141.USD","HCSG","XBI","BK4581","BK4137","BK4007","LABU","BK4588","XLV","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651460966","title":"B. Riley Analyst Initiates Coverage of Veradermics Stock (MANE) With a Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2651460966","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651460966?lang=en_us&edition=fundamental","pubTime":"2026-07-16 01:33","pubTimestamp":1784136822,"startTime":"0","endTime":"0","summary":"Veradermics stock soared on Wednesday after analyst Mayank Mamtani initiated coverage of the company’s shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/b-riley-analyst-initiates-coverage-of-veradermics-stock-mane-with-a-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/b-riley-analyst-initiates-coverage-of-veradermics-stock-mane-with-a-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651692914","title":"Veradermics Shares Gain Nearly 14% After Oral Hair Loss Drug Shows Positive Mid-stage Data in Women","url":"https://stock-news.laohu8.com/highlight/detail?id=2651692914","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651692914?lang=en_us&edition=fundamental","pubTime":"2026-07-15 22:11","pubTimestamp":1784124706,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0WM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651613614","title":"Veradermics rises 13.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651613614","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651613614?lang=en_us&edition=fundamental","pubTime":"2026-07-15 22:05","pubTimestamp":1784124324,"startTime":"0","endTime":"0","summary":"Veradermics (MANE) is up 13.9%, or $15.35 to $125.52. Published first on TheFly – the ultimate source for real-time, market-moving breaking financi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-rises-13-9-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-rises-13-9-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651469175","title":"Veradermics Shares Rise After Positive Midstage Hair-loss Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2651469175","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651469175?lang=en_us&edition=fundamental","pubTime":"2026-07-15 22:05","pubTimestamp":1784124300,"startTime":"0","endTime":"0","summary":"Shares of Veradermics were higher after the company reported positive Phase 2 results for its oral hair-loss treatment in women, supporting its late-stage development program.Shares of the biopharmaceutical company were recently up 17% at $129.29.The company said Wednesday that its extended-release oral minoxidil candidate, VDPHL01, met key efficacy endpoints in a Phase 2 trial involving women with mild-to-moderate pattern hair loss.Patients treated with the drug showed average increases of 22.7 and 23.3 non-vellus hairs per square centimeter after six months in the once-daily and twice-daily dosing groups, respectively. About 89% and 90% of patients in the two groups reported their hair coverage had \"improved\" or \"much improved\" by Month 6.Veradermics said investigators also observed improvements in hair coverage as early as Month 2. The company reported no treatment-related serious adverse events or adverse events of special interest involving the heart.The company said it expects to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103425270","title":"Positive Phase II Trial Results Announced for Veradermics' Female Hair Loss Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1103425270","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103425270?lang=en_us&edition=fundamental","pubTime":"2026-07-15 21:27","pubTimestamp":1784122054,"startTime":"0","endTime":"0","summary":"Veradermics, Inc. has announced positive topline results from a Phase II clinical trial for its oral drug candidate, VDPHL01, for treating mild-to-moderate female pattern hair loss. This news has...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651463870","title":"B. Riley Initiates Veradermics at Buy With $170 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2651463870","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651463870?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:29","pubTimestamp":1784118571,"startTime":"0","endTime":"0","summary":"Veradermics (MANE) has an average rating of buy and mean price target of $141.60. according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651688784","title":"U.S. Stocks on the Move-johnson & Johnson, Blackrock, Veradermics","url":"https://stock-news.laohu8.com/highlight/detail?id=2651688784","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651688784?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:01","pubTimestamp":1784116909,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Johnson & Johnson, BlackRock, VeradermicsWorkspace search string for individual stock moves:STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nL6N43H0ON:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTTB","LU1688375341.USD","BK4587","IE000MB6IJN5.SGD","LU0545039389.USD","LU1201861249.SGD","LU0689626769.HKD","LU1032466523.USD","BK4532","LU1046421795.USD","LU0321505439.SGD","LU0203347892.USD","LU0795875086.SGD","LU1267930227.SGD","IE00BGHQF748.EUR","LU1674673428.USD","IE0000B7K699.USD","LU0114720955.EUR","LU0426417589.USD","LU1974910355.USD","LU0211327993.USD","BK4185","LU0820561909.HKD","LU1291159041.SGD","LU1880398471.USD","LU0889566641.SGD","LU2129689431.USD","BK4612","LU2355687059.USD","BK4531","LU2112291526.USD","LU1282648689.USD","LU1048596156.SGD","BK4082","IE00BQXX3D17.EUR","LU1051769294.HKD","LU2471134523.USD","BK4550","LU0328353924.USD","LU1989764664.SGD","IE00BSNM7G36.USD","LU2023251221.USD","LU1935042991.SGD","LU0868494617.USD","LU1894683264.USD","IE00B3T34201.USD","BK4592","LU2430703095.HKD","LU2471134952.CNY","IE00B2B36J28.USD","LU1084165304.USD","LU2023250843.SGD","JNJ","LU1366192091.USD","LU0210536198.USD","LU2487616109.SGD","LU1145028129.USD","LU1280957306.USD","BK4554","LU1929549753.HKD","LU1599440770.SGD","IE00BN8TJ469.HKD","LU1861220207.SGD","LU2896262040.SGD","IE000M9KFDE8.USD","LU0067412154.USD","LU0985320562.USD","LU1066051811.HKD","BABX","LU1989771016.USD","LU2265009873.SGD","LU1152091754.HKD","LU0648001328.SGD","LU2430703178.SGD","LU1989764748.USD","LU0918141705.HKD","LU2129689514.USD","SG9999013999.USD","LU1674673691.USD","LU0354030511.USD","LU0823434740.USD","LU1066051225.USD","BK4106","LU1914381329.SGD","LU1221951129.SGD","LU1046422090.SGD","LU0052756011.USD","LU1868836914.USD","LU0130102774.USD","LU0787776722.HKD","LU0795875169.SGD","IHF","LU2756315318.SGD","BABW","LU0310800965.SGD","LU2403377893.USD","LU0124676726.USD","RXL","LU2106854487.HKD","IE0001KFT4U8.USD","IE00BFMHRM44.USD","LU1221951046.USD","LU2750360997.AUD","LU0792757196.USD","LU0708994859.HKD","LU0501845795.SGD","LU0433182093.SGD","LU2226246903.HKD","LU1242518857.USD","ISRG","JDOC","IE00BKVL7J92.USD","LU0918141887.USD","LU1267930573.SGD","BK4588","LU1064131342.USD","LU0823416689.USD","LU1496350502.SGD","PJP","LU1152091168.USD","LU0683600562.USD","LU0738911758.USD","LU0187121727.USD","SG9999014021.USD","LU0823434583.USD","FINX","LU2129689605.HKD","LU1162221912.USD","LU1629891620.HKD","LU2417539215.USD","SG9999001176.USD","IE0002141913.USD","LU0456842615.SGD","LU0964807845.USD","LU1732800096.USD","LU1244550221.USD","LU0210528500.USD","LU1804176565.USD","LU1923622614.USD","LU1551013342.USD","LU1048588211.SGD","LU1894683348.USD","LU2244417387.USD","VHT","BK4614","BK4579","LU2213496289.HKD","IE00BVYPNV92.GBP","LGHT","LU0072462343.USD","MANE","LU0882574055.USD","LU0731783394.SGD","BK4585","IE00B1BXHZ80.USD","LU0345769128.USD","BK4565","LU2089283258.USD","IE00BJT1NW94.SGD","BK4524","LU0068578508.USD","LU0106831901.USD","BK4563","SG9999001440.SGD","BK4558","PYPL","SKYY","LU2505996681.GBP","SG9999001176.SGD","IE000WAW04H5.SGD","LU2505996509.AUD","LU1121112475.USD","IBM","IE00BGHQF631.EUR","BK4503","LU1883839398.USD","IE00B19Z8X17.USD","IE00B42XCP33.USD","LU1868837300.USD","LU1668664300.SGD","IE000SO60NU8.SGD","IE00BQXX3C00.GBP","SG9999002232.USD","LU0203345920.USD","LU1043141396.HKD","LU2125909247.SGD","IE00B3S45H60.SGD","LU2023250330.USD","LU1880383366.USD","IE00BVYPNW00.USD","LU1868836757.USD","LU1481011911.USD","BK4534","LU0432979614.USD","LU2347655156.SGD","LU2756315664.SGD","IE00B19Z8W00.USD","BK4538","LU0158827948.USD","LU2063271972.USD","LU0072913022.USD","BK4227","DRAG","FHLC","LU2125909593.SGD","FTXH","LU1917777945.USD","LU1923623000.USD","BK4147","LU0234570918.USD","LU1506573853.SGD","IYH","LU1732799900.SGD","LU0053666078.USD","LU1551013425.SGD","LU0545562505.USD","LU0651947912.USD","LU0122379950.USD","IE000F7OJYX1.SGD","LU2750360641.GBP","LU2471134879.HKD","LU1868837136.USD","LU2471134796.USD","IE00BFXG0V08.USD","IE00B4R5TH58.HKD","PYPY","LU1061106388.HKD","LU1196500208.SGD","BK4566","LU1150488218.USD","IE00BZ1G4Q59.USD","LU1718418525.SGD","LU0731783048.USD","LU2236285917.USD","BK4533","AEHR","BK4575","LU2089284900.SGD","IE00B3PB1722.GBP","IE00B0JY6N72.USD","LU1119994496.HKD","LU0980610538.SGD","ISUL","LU2433249047.HKD","LU0742537680.HKD","IE00B64PRP62.GBP","LU0912757837.SGD","IE00BDGV0183.EUR","BABA","LU0348816934.USD","LU1051768304.USD","LU1983299246.USD","BK4567","KBAB","IE00B7SZLL34.SGD","BK4551","LU1244550577.SGD","LU1791807156.HKD","MEDX","LU0553294199.USD","LU0058720904.USD","LU1769817096.USD","LU1003077747.HKD","LU2456880835.USD","BK4548","LU0943347566.SGD","LU1228905037.USD","LU0097036916.USD","LU0047713382.USD","LU1008478684.HKD","LU2023250504.SGD","ONLN","BABU","LU1059921491.USD","LU2089984988.USD","LU0128525689.USD","SG9999014005.SGD","LU0426412945.USD","LU0772969993.USD","LU1823568750.SGD","BMED","LU2468319806.SGD","BK4535","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1988902786.USD","LU1515016050.SGD","LU0390134368.USD","SG9999002224.SGD","LU1509826696.USD","LU1267930490.SGD","BK4504","BBYY","BK4220","LU0345769631.USD","LU0651946864.USD","IE00BLSP4452.SGD","LU0006061336.USD","LU0985489474.SGD","SG9999014013.SGD","LU1489326972.SGD","HCA","09988","LU0251143458.SGD","BK4607","LU1228905540.USD","LU2133065610.SGD","IXJ","LU0106959298.USD","FDFF","GEHC","LU0640476718.USD","BK4139","ALBmain","IHI","IE0009355771.USD","BK4581","LU0821914370.USD","LU1066051498.USD","LU0096364046.USD","LU0979878070.USD","SGXZ57979304.SGD","BK4505","IE000BZT7R73.USD","BK4007","LU1868836591.USD","LU0157215616.USD","IE00B19Z9505.USD","LU0238689110.USD","IHE","LU1074936037.SGD","LU2148611432.USD","LU0880133367.SGD","LU0310800379.SGD","LU0070217475.USD","LU0211328371.USD","LU0320765646.SGD","LU0477156953.USD","LU1267930813.SGD","LU1951200564.SGD","BK4135","LU0310799852.SGD","IE00B19Z3581.USD","BK4598","LU0820561818.USD","PYPG","IE0034235303.USD","LU1769817179.HKD","XLV","IE00BQXX3F31.USD","LU1261432733.SGD","LU0070302665.USD","LU0321505868.SGD","IE00B775SV38.USD","ZBH","LU1150488135.SGD","LU1880398554.USD","LU0098860793.USD","BK4602","LU0797268264.HKD","BK4526","LU2360107671.USD","IE00B19Z3B42.SGD","LU0348814723.USD","LU1585245621.USD","IPAY","LU0320765489.SGD","BK4543","LU2430703251.USD","BABO","IE0002270589.USD","LU0661504455.SGD","LU0208291251.USD","GDOC","IE00B3QW5Z07.USD","LU0061475181.USD","CLIX","BK4568","BK4134","IE00B5TLWC47.USD","LU0289739699.SGD","LU1235294995.USD","LU0878866978.SGD","LU1242518931.SGD","LU0820562030.AUD","BK4122","LU2602419157.SGD","LU0949170772.SGD","BK4502","LU1670628061.USD","IE00BJJMRZ35.SGD","LU1057294990.SGD","IE00BYQQ9H92.USD","LU2592432038.USD","BK4527","LU0128525929.USD","LU0345770993.USD","BLK","LU1670627923.USD","LU1066053197.SGD","IE00BLSP4239.USD","LU1105468828.SGD","SG9999014039.USD","LU0029864427.USD","LU0354030438.USD","LU1366333091.USD","LU1430594728.SGD","BK4559","LU0130517989.USD","LU1951198990.SGD","LU0689472784.USD","LU2264538146.SGD","IE00BBT3K403.USD","LU0345770308.USD","TDIV","LU1481011671.HKD","LU0466842654.USD","LU1244550494.USD","IE00BF5LJ272.USD","IE00BFXG1179.USD","LU1032955483.USD","EKG","LU0994945656.USD","LU2324357040.USD","LU1043141123.HKD","LU1861217088.USD","LU1778281490.HKD","LU0234572021.USD","LU0079474960.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651450089","title":"Veradermics' Potential Female Hair Loss Treatment Restores Hair in Phase 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2651450089","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651450089?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:00","pubTimestamp":1784116807,"startTime":"0","endTime":"0","summary":"Veradermics'  VDPHL01 achieved rapid onset of hair growth with the majority of participants in a phase 2 clinical trial of females with mild-to-moderate pattern hair loss, the company said Wednesday.The orally-administered extended-release formulation showed improvement in hair coverage as early as the second month and \"consistent treatment effect\" with around 88.9% dosed once a day and 90.0% with those dosed twice a day reporting \"improved\" or \"much improved\" results after six months, the company said.VDPHL01 also showed a \"favorable\" safety and tolerability profile consistent with previous trials, the company said.Veradermics is planning a phase 2/3 clinical trial with results expected in H1 2027, the company said.Shares of the company were up 4.8% in recent premarket trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651457142","title":"Veradermics Rises as Oral Hair Loss Drug Shows Positive Mid-stage Data in Women","url":"https://stock-news.laohu8.com/highlight/detail?id=2651457142","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651457142?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:18","pubTimestamp":1784114318,"startTime":"0","endTime":"0","summary":"BUZZ-Veradermics rises as oral hair loss drug shows positive mid-stage data in women** Shares of drug developer VeradermicsMANE.Nrise 6.3% to $117.14 premarket** Co says its experimental oral hair los","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nL4N43H0XO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651745716","title":"Veradermics announces results from Phase 2 trial of VDPHL01","url":"https://stock-news.laohu8.com/highlight/detail?id=2651745716","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651745716?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:10","pubTimestamp":1784113852,"startTime":"0","endTime":"0","summary":"Veradermics (MANE) announced positive topline results from its open-label Phase 2 clinical trial evaluating VDPHL01, a proprietary extended-release...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-announces-results-from-phase-2-trial-of-vdphl01-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-announces-results-from-phase-2-trial-of-vdphl01-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HYLG","PSIL","IDNA","MEDX","BBC","BK4007","GDOC","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651745227","title":"Veradermics’ Oral Vdphl01 Delivers Positive Study ‘207’ Phase 2 Clinical Trial Results in Female Pattern Hair Loss Ahead of Upcoming Phase 2/3 Study ‘306’ Readout","url":"https://stock-news.laohu8.com/highlight/detail?id=2651745227","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651745227?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:00","pubTimestamp":1784113202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA4TB420:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651522424","title":"Veradermics - Vdphl01 Shows Favorable Safety with no Treatment-related Serious Adverse Events or Cardiac Aesis","url":"https://stock-news.laohu8.com/highlight/detail?id=2651522424","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651522424?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:00","pubTimestamp":1784113202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA4TB420:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651227452","title":"Veradermics - Vdphl01 Shows 88.9%-90% Improvement in Hair Coverage at Month 6 in Phase 2 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2651227452","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651227452?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:00","pubTimestamp":1784113202,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA4TB420:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651045285","title":"Veradermics Initiated at Buy by B. Riley Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2651045285","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651045285?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:37","pubTimestamp":1784111820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MANE/analyst-ratings(END) Dow Jones NewswiresJuly 15, 2026 06:37 ET","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651596104","title":"Veradermics initiated with a Buy at B. Riley","url":"https://stock-news.laohu8.com/highlight/detail?id=2651596104","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651596104?lang=en_us&edition=fundamental","pubTime":"2026-07-15 17:30","pubTimestamp":1784107818,"startTime":"0","endTime":"0","summary":"B. Riley initiated coverage of Veradermics (MANE) with a Buy rating and $170 price target The firm views the company’s lead asset VDPHL01, an exten...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-initiated-with-a-buy-at-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-initiated-with-a-buy-at-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651743572","title":"Veradermics Inc : B. Riley Initiates Coverage with Buy Rating; Target Price $170","url":"https://stock-news.laohu8.com/highlight/detail?id=2651743572","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651743572?lang=en_us&edition=fundamental","pubTime":"2026-07-15 11:23","pubTimestamp":1784085815,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43G14D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651482521","title":"Veradermics to Discuss Phase 2 Results for Oral Minoxidil Hair-loss Drug Vdphl01 on July 15 Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2651482521","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651482521?lang=en_us&edition=fundamental","pubTime":"2026-07-15 06:54","pubTimestamp":1784069661,"startTime":"0","endTime":"0","summary":"Veradermics to discuss Phase 2 results for oral minoxidil hair-loss drug VDPHL01 on July 15 webcastVeradermics scheduled an investor call and webcast for July 15, 2026 at 8:00 a.m. ET to review Phase ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL6QCSHw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649082939","title":"Veradermics is Maintained at Buy by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2649082939","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649082939?lang=en_us&edition=fundamental","pubTime":"2026-07-08 00:27","pubTimestamp":1783441620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MANE/analyst-ratings(END) Dow Jones NewswiresJuly 07, 2026 12:27 ET","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":124,"code":"91000000","status":"200"}]}}